Previous studies have already proved the regulation function of SMAD2, SMAD4, and TGFBR2 in cancers (Matsuzaki et al., 2009; Zhu et al., 2020), and these genes were also found related with miRNAs that strongly correlated with tumor features, indicating the potential function and clinical utility in immunotherapy. This evidence concerns the gene SMAD4 and cancer.